StemCell Therapy

James Chen is seen with children working on his philanthropic cause to give everyone access to vision correction if they need it. Photo provided to China Daily

Clearly, the eyesight charity set up by Chinese philanthropist James Chen, is to merge with the International Agency for the Prevention of Blindness next year in a bid to increase efforts in supporting better vision globally.

Over the last 15 years, Chen had made it his mission to tackle poor vision. He has been funding and leading work to promote universal access to glasses and said the merger is a step closer to his dream of helping the whole world see clearly.

The International Agency for the Prevention of Blindness, or IAPB, is a network of more than 150 members working in international eye health and leading global advocacy body for the sight sector.

The new partnership, which will come into effect on Jan 1,2021, was created to combine the two organizations' advocacy and campaigning expertise as a way to renew pressure on governments and global leaders to end the vision crisis.

In a report published in October, the World Health Organization said it would cost an estimated $14.3 billion to treat the 1 billion people already living with visual impairment or blindness from cataracts, and short and far-sightedness.

Chen said: "IAPB have long been a leader in the vision sector. I am delighted that we will be able to combine their unprecedented authority and reach within the sector with our ground-breaking campaigning work, particularly on school eye health, work-based sight tests and the links between vision and delivery of the Sustainable Development Goals."

Along with his ongoing interests as founder of Vision for a Nation and Adlens, Chen will play an even more active role in the vision sector following the merger, as a global ambassador for IAPB.

Peter Holland, chief executive of the IAPB, said that the unprecedented move marks the "next exciting phase in the battle to deliver vision for everyone".

"This is a hugely important development for the sector and comes at a time when poor vision is rising across the world," Holland said. "Clearly has made massive strides forward in waking up the world to the scale of the vision crisis. This merger will provide the IAPB with renewed vigor and expertise in effective campaigning. It will enable us to make the case even more effectively about the urgency and value for money of tackling the global vision crisis."

Read the original post:
Leading sight organizations to merge in fight to end global crisis in vision - Chinadaily USA

NESS ZIONA, Israel--(BUSINESS WIRE)--Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX), an innovator in automotive vision systems, announced today that its wholly owned subsidiary, Eye-Net Mobile Ltd., will start a pilot project with a multi-billion dollar global Japanese technology company to test its Eye-Net Protect cellular-based V2X (vehicle-to-everything) accident prevention solution.

The pilot project will be used to validate the Eye-Net solution capabilities and its technical specifications. Upon successful completion, the Japanese technology company may proceed to commercial integration of the Eye-Net solution into its IoT platform which currently serves millions of users.

This pilot project marks an important milestone on Eye-Net Mobiles commercial roadmap. The technology company will be the first to evaluate the software development kit (SDK) configuration of Eye-Net Protect. Integration with a global Japanese company has the potential to allow our life-saving accident prevention solution to protect millions of users daily, said Dror Elbaz, COO & Deputy CEO of Eye-Net Mobile.

The Eye-Net Protect V2X solution is designed to protect the most vulnerable road users in real time - including pedestrians, cyclists, scooter drivers and car drivers - by providing collision alerts when the road users have no direct line of sight. An SDK configuration allows Eye-Net Mobile to integrate its solution with leading location-based products such as wearable devices, dashboard cameras, navigation aids, infotainment systems, third-party applications and other smart devices.

For more information about Eye-Net Mobile, please visit http://www.eyenet-mobile.com, or follow the Companys LinkedIn page, Eye-Net Mobile; Twitter, @EyeNetMobile1; and Instagram channel, Eyenetmobile1, the contents of which are not incorporated into this press release.

About ForesightForesight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX), founded in 2015, is a technology company engaged in the design, development and commercialization of sensors systems for the automotive industry. Through the companys wholly owned subsidiaries, Foresight Automotive Ltd. and Eye-Net Mobile Ltd., Foresight develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications. Foresights vision sensor is a four-camera system based on 3D video analysis, advanced algorithms for image processing, and sensor fusion. Eye-Net Mobiles cellular-based application is a V2X (vehicle-to-everything) accident prevention solution based on real-time spatial analysis of clients movement.

The companys systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is targeting the Advanced Driver Assistance Systems (ADAS), the semi-autonomous and autonomous vehicle markets and predicts that its systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform and advanced technology.

For more information about Foresight and its wholly owned subsidiary, Foresight Automotive, visit http://www.foresightauto.com, follow @ForesightAuto1 on Twitter, or join Foresight Automotive on LinkedIn.

Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates" and similar expressions or variations of such words are intended to identify forward-looking statements. For example, Foresight is using forward-looking statements in this press release when it discusses the terms of any agreement between Eye-Net and the global Japanese technology company, that the pilot project will be used to validate the Eye-Net solution capabilities and its technical specifications, that upon successful completion, the Japanese technology company may proceed to commercial integration of the Eye-Net solution into its IoT platform, and that potential integration with a global Japanese company has the potential to protect millions of users daily. Because such statements deal with future events and are based on Foresights current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements of Foresight could differ materially from those described in or implied by the statements in this press release.

The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed under the heading "Risk Factors" in Foresight's annual report on Form 20-F filed with the Securities and Exchange Commission ("SEC") on March 31, 2020, and in any subsequent filings with the SEC. Except as otherwise required by law, Foresight undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Foresight is not responsible for the contents of third party websites.

Read this article:
Foresight: Eye-Net Mobile and Global Japanese Technology Company to Start Pilot Project - Business Wire

Nearing 92, Cheri McDaniel is losing her eyesight. But her vision for new ideas is going strong.

Early this year, McDaniel finished her third book, and she says a fourth one might be on the way. On the West Feliciana Parish property where she is riding out the coronavirus pandemic with family members, she is creating plans for the gardens, ponds and structures she has built over the past five decades.

She also continues to raise money for charity work in Haiti and Swaziland through Rotary an organization she joined while creating a medical and educational mission in Mexico. She was only 75 then.

This likely surprises no one who knows McDaniel, who also has been a house designer, builder and antique store owner.

"I think her energy comes from her passions, either her passion to write, her passion to help others, her passion to serve," said Martha Stuckey, president of theCapital City Rotary Club, of which McDaniel is a member.

McDaniel suggests she doesnt deserve much credit.

Im a simple farm girl, she said. I feel that God is driving the vehicle of my life or I wouldnt still be here. These things just evolve.

Its been that way since McDaniel, who was born in 1928, grew up on a Union Parish farm through the Great Depression, earned a home economics degree and became a hospital dietitian. She met her first husband, Jack Smith, at LSU, and his oil industry work took them to El Dorado, Arkansas, and Memphis, Tennessee, before coming to Baton Rouge in 1947.

In each location, McDaniel designed the couple's home. Despite no formal education in construction or architecture, she discovered she had the ability to visualize a house and taught herself how to draw up plans that carpenters and other tradesmen could follow.

In Baton Rouge, she was a homemaker until their only child, Susan, was old enough to go to school. Since being a dietitian no longer appealed to her, she told Jack in 1958 that she was going to design and build homes for a living. She says she was the only woman to run such a company in Baton Rouge at the time and designed about 200 homes in 27 years.

I never did two houses alike, McDaniel said. Id meet with them, find out what they really wanted to have in a house, what was their budget, and it was my goal to be able to give them everything they wanted, and most of the time I was able to do that within their budget. And they left me alone.

Along the way, she founded Fireside Antiques in 1982, which Susan managed until becoming pregnant with quadruplets in 1986, so McDaniel took over and ran the business until 2003.

When she was in her mid-70s, sensing that God was calling her to the mission field, she moved to San Miguel de Allende, Mexico, and started the Holistic Educational Center, a facility that provided both medical care and education to improve the lives of impoverished residents there. She wrote grant applications that helped fund a retinopathy clinic at the local hospital there.

However, after four years, the 6,000-foot altitude was causing McDaniel fainting spells, and her second marriage was ending, so she returned to Baton Rouge. She joined the Capital City Rotary Club upon her return, writing grant proposals that created funding for outreach projects.

McDaniel moved to St. James Place retirement community. That's where she got the inspiration to write.

It began with her life story, titled He Lays the Stones for Our Steps, which she followed with Snazzy Seniors, telling stories of interesting and inspirational people she met. She sells the books through her Rotary club, and its proceeds go to club projects.

In her third book, Descending Toward Darkness, Illuminated by Faith, she tells the stories of people shes met who have come through challenges. God, she said, gave her the title. It was printed just before St. James Place went into lockdown in March, which McDaniel believes is no coincidence.

God had to have known that this pandemic was coming to give me such a strange title, she said. I wasnt planning to write a third book. I had never studied creative writing. So, God is still keeping me going.

The title also reflects some of McDaniels own experience.

A cancer survivor, she has faced numerous recent health challenges: congestive heart failure, shingles, knee surgery and failing eyesight that forced her to hand-write passages of the book in large letters so someone else could type them. She continues to write, currently focusing on spiritual topics.

I am now legally blind, but nothing seems to stop our heavenly father, she said. My writing has become a wonderful adventure.

One of many.

Every morning after breakfast, an assistant drives her in a golf cart for two hours to look over 388 acres near Lake Rosemound where McDaniel has built houses for family members and created a forest and garden from what was once a cow pasture.

McDaniel once held Easter sunrise worship services on the property and wanted to build a church there, but when the family didnt agree due to lack of suitable parking space, she built a small, open-air meditation chapel. Hundreds of encore azaleas bloom multiple times a year, creating vibrant color even in the August heat.

Its like I feel reborn in this environment, McDaniel said. Im still alive, and Im still being inspired by the infinite creator. I take no credit. His presence is so strong.

Read more here:
Cheri McDaniel is almost 92, but that's not slowing her down one bit - The Advocate

In the commercial fleet world, driver safety is above all, and it becomes even more crucial when a semi-trailer is hauling a couple of tons of dangerous or hazardous materials cross country. As weve witnessed in the past, the potential spills caused by the Oil & Gas industry fleets can cause immense environmental damage, if or when a mistake is made. Just the threat of a catastrophic oil spill hitting the news is poised to doom public opinion against the trucking company and supplier. Further highlighting the necessity for hazardous material drivers to stay alert and safe on the road, creating a potential problem that demands an innovative solution.

Israeli company Eyesight Technologies, which leverages AI and computer-vision technologies for a safe driving experience, announced that its partnering with French fleet management conglomerate GloboConnect, a leading provider of telematics systems for fleets.

"The partnership is a major part of our effort and investment to improve road safety," said Yannick GUIDEZ CEO of GloboConnect. "The addition of Eyesight Technologies' driver monitoring solution to our telematics capabilities enables us to extend our driver safety solutions to include monitoring inside the cabin, allowing our customers to ensure better driving practices and the safer transport of dangerous goods in the oil and gas trucking industry."

The joint venture will focus efforts towards developing a driver monitoring telematics device, tailored for the Oil & Gas industrys fleets. The device will combine Eyesight Technologies' computer vision and AI-based driver monitoring system (DMS) along with Globo's telematics infrastructure and hardware to improve road safety for an estimated 50,000 vehicles in oil & gas fleets.

"This partnership is another meaningful step towards creating safer driving environments in the fleet industry," said David Tolub, CEO of Eyesight Technologies. "An aftermarket DMS solution is a valuable addition to existing telematics offerings, increasing the safety and efficiency of fleets."

Read the original here:
Eyesight Technologies partners with GloboConnect to bring AI-driven safety to Oil & Gas Fleets - Geektime

Many of the animals, birds, and insects that are part of the Natural World have unique and useful uses and features related to their heads. This article covers a few of these which might explain such things as why a Dog tilt their heads when they hear a sound, and the Owl and the Praying Mantis are the only predators that have a special bone structure that is quite useful for them.

Now that I have covered Tails in article #1 let's move to the other half of our discussion on some of the unique features found in animals, birds, and insects in the natural world.

Just seeing a Dragonfly must be terrifying if you are a gnat, mosquito, or other small bugs. To us, humans, they are unique insects that are mostly quite nice to see. The eyes of a dragonfly take up 90% of its head. Their eyesight is the key to its hunting, and flying skills allow them to have a 95% success rate when hunting. They use this sight to judge the speed and trajectory of the target prey and adjust their flight to intercept the prey and snag it from the air.

The Common Mole's nose, found at the pointed end of its head, is the only part of its body it is not uncomfortable with. Despite devastating blindness and inadequate tactile sensitivity, the moles excel at finding food sources. Scientists have found that except for a few species of dogs such as the Bloodhound, which can tell the direction a smell comes from and follow it, the common mole may be the only animal with what is known as natural stereo smelling ability.

Look around, and maybe you can turn your head to the left or right and move it up and down with ease. You can also move your eyes around in many different directions, and a few of us can even cross our eyes. In the animal world, there are loads of various kinds of eyes that see the world in distinctive ways. Owls cannot move their eyeballs around in their sockets very well. Yet they do have particularly good night vision. Their eyes are positioned on the front of their heads like many of their fellow predators. They have what is thought of as binocular vision.

While Owls might not be able to move their eyeballs, they more this makeup for this by turning their heads up to 270 degrees to the right or left. That is more than twice what we humans can do. The owls have what is called a pivot joint in their bone structure that allows this broad range of movement. There is only one other predator that can do this. It is the Praying Mantis.

What is magnetite? It is a naturally occurring mineral that reacts to magnetic fields. Scientists believe that many animals may have small amounts of it in their brains, allowing them to sense the magnetic fields produced by the earth. However, Dolphins and some whales have magnetic rocks in their heads. Bats and birds (especially pigeons) can navigate vast distances without any clues as to where they are other than the presence and shape of the magnetic fields, which they sense using the magnetite in their brains. Dolphins and many species of whalecan navigate enormous miles of open ocean by using these same, but larger, rocks of this substance within their brains. They are navigating by the magnetic fields they have used during their entire life. They may even think they are in the open and deep waters but can be dangerously close to the shore.

Have you ever noticed that many species of Birds head-bob when they are walking? The term head-bobbing is used for the apparent back and forth movement of their head as they walk and is a bit of a misnomer. The birds do not bob their heads, ---instead, they move their body forward and leave their head behind. They then thrust their head forward past their body. This crazy behavior is thought to help critical aspects of their vision during their forward movement.

If you happen to see a deer bobbing its head, it is not like a bird. A deer's pupils are not like humans; instead, they are more oval and oriented horizontally to give them a wider field of view. We humans can see about a 120-degree range of vision. Having their eyes on the side of their head plus having the oblong pupils, a deer has close to a 300 degrees range. While this gives them a wider angle of vision, it does impact their vertical sight. That is one reason hunters sometimes use a tree stand. Because of this vertical limit, they bob their head to improve their vertical vision.

When you are out on Presque Isle, I am willing to bet that many of my readers think they see an eagle flying overhead. Well, most times, you have spotted a turkey vulture and not an eagle. While looking somewhat like an eagle, they have a genuine bald head while the eagle has white feathers. At close range, they resemble the wild turkey, hence their name. They are the only scavenger bird that cannot kill their prey. This is because their feet are like chickens and not an eagle's or a hawk's. Instead, they have a powerful beak that can tear through even the most robust cowhide. They also have an extraordinary sense of smell that allows them to locate a dead animal from over a mile away.

Monkeys use faces like name tags. They all boast the most colorful faces in the mammal kingdom, and they are not just for show. Like humans, they distinguish friend or foe by facial features, which have evolved to be uniquely distinctive in their close-knit communities.

Why do dogs tilt their heads when they hear sounds. The human ear is engineered to pick up a sound so efficiently that you do not need to turn toward the sound to capture it. That is not so with a dog. Dogs have flaps that partially or entirely cover the ear canal and serve as a barrier to sound. Luckily, the canine ear flap is moveable so the dog can easily make the necessary adjustment and tilt its head toward the sound.

Rabbit ears have a unique shape. Yes, they are long. However, they also have a curve that turns them into satellite dishes place upon a bunny's head. Their shape helps catch and amplify all sounds. Because rabbits are prey species, they must continuously monitor for small sounds that may show a predator is near. They also need to know where the sound is coming from. The length and their ability to move, turn and tilt their ears give rabbits a directional location of the sound. They also use their ears to signal other rabbits. People who have rabbits often tell that rabbits "waggle" their ears at their humans to get interaction from them.

In ending, I know there are many more different and interesting facts about animals, and I may in the future gather in some others and post here on Goerie.com.

See you on the park!!

Gene Ware is a published author of 9 books and is on the boards of the Presque Isle Light Station and was past Chairman of the Tom Ridge Center Foundation, and the Presque Isle Partnership. He is also a goerie.com contributing writer. Send questions and comments to ware906@gmail.com

Read more:
Heads or Tails - - The choice is up to you - - - Heads - Part #2 - GoErie.com

QUEENS A Bronx mother, who watched her only son rally from a gunshot wound to the head on July 4, 2019, mourned his loss outside the Queens rehab center where he spent the final months of his life.

He lived this for 13 months, Nicole Backmon said of her son Sammy, 21, outside the Park Terrace Care Center in Corona, Queens. He was a warrior.

Sammy Backmon was one face of gun violence in a city where most victims dont make headlines.

At age 20, he suffered a traumatic brain injury when he was hit by a bullet while coming home to the family apartment on Hull Avenue in the Bronx; he was celebrating the Fourth of July holiday.

He was walking home from the train and shots were fired, his uncle, Alex Rodriguez, said, and he got hit in the back of the head.

Sammy Backmon spent weeks in the intensive care unit at St. Barnabas Hospital, where he suffered brain damage that affected his speech, memory, mobility and eyesight.

The vision was really, really bad, Sammys uncle recalled. He couldnt see anything, except for a blurry silhouette.

But the family said Sammy Backmon improved remarkably after spending two months at Burke Rehab in White Plains. He was later transferred to the facility in Queens that accepted Medicaid payments.

His vision gradually got much better.

In February, wearing a helmet on his damaged skull, family cell phone videos showed physical therapists helping Sammy Backmon to start walking again.

He was almost walking independently, his mother said.

But the young man was having recurring issues with blood clots and circulation.

He made it through the height of the COVID-19 pandemic in new York without getting sick, but it did have an impact on his general health.

When COVID hit, PT really slowed down, Sammys uncle recalled. He started gaining weight, he wasnt moving, his circulation wasnt good.

Surgery to put a steel plate in Sammy Backmons head was repeatedly delayed.

On June 26, Sammy Backmon enjoyed a reunion with his extended family, dining outdoors in the Bronx after a visit to a medical clinic there.

His uncle took videos, joking it was Quarantine Friday, while one of Sammy Backmons little cousins ran around the table.

In late July, Sammy Backmon finally underwent the surgery to put the plate in his head where a piece of his skull used to be.

The family said it was a success.

But on August 10, Nicole Backmon got a call she wasnt prepared for.

Sammy Backmon, her only son, was dead at 21.

They think he had a seizure, Nicole Backmon said.

Sammy Backmons death certificate said he died of complications from a gunshot wound. His family wants an autopsy performed, and theyve started a GoFundMe page to defray funeral expenses.

His mother wants the public to know he endured a lot during the months he spent in a long-term care facility.

My son suffered in silence, Nicole Backmon said. He didnt tell me everything.

Read more from the original source:
Bronx son survived gunshot wound to head, but recovery took its toll, and his life - WPIX 11 New York

If you have problems with your eyesight and struggle to watch a lot of TV, Amazons latest update to its Fire TV platform could help resolve those issues.

Amazon has announced Text Banner for its Fire TV platform. Its an assistive technology designed for those with visual impairments and narrow field of vision, including conditions such as macular degeneration, glaucoma and retinitis pigmentosa.

Text Banner works by consolidating the onscreen text of a selected item/icon into a compact, rectangular banner that appears in a fixed location on the screen.

The entire Fire TV user interface, Prime Video and all apps on Fire TV work with Text Banner, which Amazon says makes it easier for these customers to enjoy movies, videos. Users can customise the feature by the changing colours as well as the size of the box and the text bu heading to Settings> Accessibility > Text Banner.

Marc Powell, Strategic Accessibility Lead at RNIB, said: The accessibility of tech is changing the lives of blind and partially sighted people giving a greater sense of freedom, increasing independence and breaking down barriers to create a more inclusive world.

Amazons move to begin making its Fire TV platform more accessible for people with vision impairment is another powerful message of inclusivity to the industry and we hope to continue seeing accessibility improve as a trend across the technology sector in the years ahead.

The Text Banner feature is available now. The cheapest available Fire TV Stick costs 44.99. Prime Video costs 7.99/month or you can get it as part of a Prime Membership, which costs 79/year.

TV & Audio Editor

Kob began his career at What Hi-Fi?, starting in the dusty stockroom before rising up the ranks to join the editorial and production team as the Buyers Guide editor. Experienced in both magazine and

Unlike other sites, we thoroughly review everything we recommend, using industry standard tests to evaluate products. Well always tell you what we find. We may get a commission if you buy via our price links.Tell us what you think email the Editor

Read the original:
Amazons latest Fire TV feature is designed to assist the visually impaired - TrustedReviews

The problem of mass death of birds from a wind turbine could be resolved through painting one blade black. That makes it easier for birds to avoid a deadly encounter, say the findings published in Ecology and Evolution.

The recent study found that painting one of the four white blades on a wind turbine black significantly decreases the number of dead birds by 72 per cent.

In fact, wind farms would kill twice as many bats as they do birds, the figures would be: 111 333 birds per turbine per year, and 222 666 bats per turbine/year, according to Mark Duchamp, head of Save the Eagles International.

According to the researchers from the Norwegian Institute for Nature Research conducted a trial on the remote island of Smola comparing how many birds were killed by four painted turbine compared to their untouched neighbours.

During seven and half years, the researchers regularly scoured the bottom of the turbines with specially trained sniffer dogs to identify any bird carcasses. The difference between periods when one of the four blades was painted black was impressive.

For the eight turbines included in the research four painted and four left bare a total of 1,275 searches were conducted between 2006 and 2016.

A total of 82 carcasses were found and statistical analysis revealed the birds which benefit the most from the pained blades are raptors and large soaring birds.

This includes eagles and vultures, who have been high-profile casualties of wind turbines. No white-tailed eagle carcasses were recorded after painting the blades.

The study also found that while the number of dead birds dropped at painted turbines, it did not trigger a spike in the number of casualties at neighbouring turbine zones. As the scientists suggest, the reason painting a single blade works is due to a phenomenon called motion smear.

This means that, although birds often have exceptional eyesight, the rotating blades appear invisible. Birds have extremely high-resolution eyesight in their peripheral field of vision, and the front-facing eyesight is not as good.

Thus, within assumed open airspace, birds may therefore not always perceive obstructions ahead thereby enhancing the risk of collision, the study says.

See original here:
Bird deaths from wind turbine's drop when one blade is painted black - PoliticalLore.com

Author and Motivational Speaker, Chad Foster

Chad Fosters life took a detour when he went blind in his late teens. Now hes an executive at Red Hat, the worlds largest open source software company, an author, and a motivational keynote speaker. His memoir, Blind Ambition (published by HarperCollins Leadership), will publish in early 2021.

I had the opportunity to interview Chad recently. Here are some of the highlights of that interview:

Jill Griffin: Take us back to when you lost your sight

Chad Foster: I was studying at the University of Tennessee when my eyesight really began fading. I was diagnosed at three-years-old with retinitis pigmentosa, a genetic eye condition, and doctors told my parents Id eventually go blind.

For me, it was really just an intellectual concept, because I played sports, drove a car, and other things people take for granted. I thought maybe Id be an outlier, but my eyesight started failing in college. Going blind changed the course of my life. It was a pretty dark time, but the fire inside of me didnt flame out.

Griffin: It must have been a challenging period. What was your response?

Foster: It was dreadful. Beyond the striking emotional challenges, I was a visual learner, which wasnt useful as a blind guy. So I changed my major from pre-medicine to business. My mom read all of my business books to tape, I recorded the lectures, and I listened to the books and lectures multiple times. It turned out I was a better blind student than sighted student. I made straight A's and the Deans List, and upon graduation moved to Atlanta to work for Anderson Consulting (currently Accenture). I was terrified my support system was gone, I didn't know Atlanta, I was working in an industry requiring significant travel. Ultimately, I had to decide which fear I could live with. The fear of failing, or the fear of not knowing my potential.

Griffin: So you became more comfortable with the fear?

Foster: I learned to get comfortable with discomfort. When I was in college, my well-intended parents built a basement for me, just in case I didn't make it in the world. I started thinking of it as the loser basement, and vowed to never spend a day there. If we let others control our expectations for ourselves, whether that be our well-meaning parents or society, where will we end up? We need to live life based on our own vision of greatness.

Griffin: Andersen Consulting is a prestigious Fortune 500 company. What do you think made them seek you out?

Foster: Outstanding companies look for intelligence, drive and a willingness to try. When I explained my journey during the interview, any doubts about my determination were extinguished. In tech its easy to find a developer, but skills have a short shelf life because what will technologies look like in ten years? Whats important is finding people who are smart, naturally curious, and determined. The landscape changes so quickly that hiring for skills is less durable than hiring for traits.

Griffin: Tell me about the software you developed that Oracle said was impossible?

Foster: I taught myself to engineer my own software, and I got so good at it that people would seek me out. One day a colleague called. They had a customer with a blind employee who couldnt do his job because of a problem between their customer relationship management software and screen-reading software.-

So, I said, Yeah, I'll talk to the client, and then I started doing what I always do, which is dig for a solution.

A year or two later, I got an email asking for help with Siebel, and I responded casually saying, I've done this before.

So, we all hopped on a call me, the prospective client and their technical account manager from Oracle, the vendor of the screen-reading software, and my former client and they said, Weve talked to Oracle and the maker of the screen-reading technology and, it's not possible. And then my client said, Actually, Chad's already done it, and I've been using the technology for the last two years. Oracle started sending me clients after that.

Griffin: You were the first blind graduate of the Harvard Business Schools Program for Leadership Development. What did you learn there?

Foster: There are no black and white answers in the world of leadership. Weve got to think about and manage shades of grey. We explored the nuances of real-world business cases and observed them from many different vantage points. I learned a lot from the faculty, as well as my fellow executive classmates.

Griffin: Youre publishing your first book. Can you tell me about that?

Foster: Blind Ambition is a memoir, because the best way for people to digest the lessons Ive learned is to hear the stories from my life. Fundamentally, we all become the stories that we tell ourselves. Its about how I learned resilience by attending the school of hard knocks, being able to distinguish whats inside my sphere of influence, such as my ability to use a computer, write code, and get on stage and deliver an inspirational keynote without notes, and learning how to accept and even embrace things that are outside my sphere.

If you tell yourself youre a victim, that's how youll be. If you tell yourself I've got this, I'm owning this blindness thing, and Ill make it look good, then that's how youll be. And its a self-fulfilling prophecy, because we all become the stories playing in our minds. We can choose to move our mindset from victim to visionary.

We have to be prepared to reinvent ourselves. My blindness came in terrible wrapping paper, but its a gift that enables me to help others in a way thats not otherwise possible.

Griffin: What are some of the major themes that you touch on in your workshops?

Foster: The number one pillar is dealing with change. When going blind, I had to deal with the loss of my self-identity. I never aspired to grow up and be a blind guy, so I had to create a vision of greatness that included my blindness. All of us have faced the question what do you want to be when you grow up? No one said, I want to be a blind guy. But when life changes, we have to figure out how to visualize success. Now, I provide a framework for building resilience. Creating some space to be mindful and intentional about that allows us to respond to challenges more effectively. Coupled with strategy, effort, determination and a plan, its a winning formula.

Griffin: What inspired you to give motivational keynotes in front of thousands of people?

Foster: My tipping point was giving the graduation speech at Harvard. I had a feeling Id be elected so, being a Type-A personality, I met with a professional speaker and prepared my talk before we even voted. When I was elected, I delivered a very moving keynote. One classmate was so moved that he decided to commission an opera inspired by my story. Several others shared how Id inspired them as they faced traumatic situations. I was also moved a feeling of electricity coursed through my body, and I knew I was doing the right thing. At that point I saw how powerfully I could help others if I were to be intentional about it.

Excerpt from:
To Win, Decide Which Fear You Can Live With - Forbes

August 16, 2020

Vision scientist David Williams is third consecutive recipient with Rochester ties.

For the third consecutive year, a member of the Rochester community has been recognized by the Association of University Professors of Ophthalmology (AUPO) for outstanding vision research.

David Williams, the William G. Allyn Professor of Medical Optics, has been selected by the association as the 2021 recipient of the RPB David F. Weeks Award for Outstanding Vision Research. The award annually recognizes and celebrates an outstanding ophthalmic vision scientist whose research has made meaningful contributions to the understanding or treatment of potentially blinding eye diseases.

The previous two recipients of the award were:

2020: Christine Curcio 81 (PhD), who is now the White-McKee Endowed Professor in Ophthalmology at the University of Alabama and director of the Age-Related Macular Degeneration Histopathology Lab.

2019: Jayakrishna Ambati 98M (Res), who is now a professor of ophthalmology at the University of Virginia.

Williams, who holds joint appointments in optics, brain and cognitive sciences, ophthalmology, and biomedical engineering, is widely regarded as one of the worlds leading experts on human vision. As a pioneer in using new technologies that improve the eyesight of people around the world, he and his research team demonstrated the first adaptive optics system for the eye, making it possible to image individual retinal cells. The techniques developed by Williams and his group have also improved vision in patients with contact lenses, intraocular lenses, and laser refractive surgery. For example, the methods Williamss group developed are used in many of the Lasik procedures conducted worldwide today.

Williams additionally serves as director of the Center for Visual Science, a research program consisting of more than 37 faculty members from seven different departments dedicated to understanding how humans see, as well as the disorders that compromise sight.

Williams joined the Rochester faculty in 1981, and served as dean for research in Arts, Sciences & Engineering from 2011 to 2019. He is a fellow of the Association for Research in Vision and Ophthalmology, the Optical Society of America, and the American Association for the Advancement of Science. In 2017, he was named a member of the National Academy of Sciences.

The Weeks Award is scheduled to be presented to Williams at the AUPO Annual Meeting in February 2021.

Tags: Center for Visual Science, David Williams, Department of Biomedical Engineering, Department of Brain and Cognitive Sciences, Department of Ophthalmology, Hajim School of Engineering and Applied Sciences, Institute of Optics

Category: University News

See original here:
Rochester researcher recognized with national award for outstanding vision research - University of Rochester

Itchiness, tiredness and sometimes burning sensation in the eyes can be a sign of eyestrain. Too much exposure to screen is one of the leading causes of eyestrain. Here are some tips you can follow to prevent this.

Exposure to screens for too long can negatively affect your eyes in several ways

When at home, you tend to spend more time staring at the screens. Too much exposure leads to several harmful effects. Eyestrain is a common condition in this digital age. Eye strain can irritate the eyes, headaches, blurry vision, dry eye, pain in neck, shoulder and back, excessive stress, poor vision and trouble in focusing. This condition can also be a result of driving for long-distance as it can make your eyes tired. But the use of digital gadgets is one of the leading causes. If left uncontrolled eye strain can lead to several problems like macular degeneration, sleep disturbances and in some cases cataract.

Eyestrain can causes discomfort in performing day to day activities too. Here are some tips you can follow to prevent this condition.

It is usually advised to take a 20 seconds break after continuous exposure to screens for 20 mins. Try to create a balance between your work and breaks so that your eyes get enough rest.

Take frequent breaks to give your eyes a break from the screenPhoto Credit: iStock

While working or watching something do not keep the screen to close to your eyes. Ideally, it is advised to keep a minimum distance of 20 inches between the screen and your eyes.

Also read:Eye Care: 6 Best Tips You Need

Not just the distance you should also maintain the right angle of the placement of the screen. Keep the screen at the level of your eyes or slightly below. It should not be above the eye level or too low (staring at low level can lead to text neck).

These days a variety of lenses are available. You can consult an eye specialist to get the perfect glasses for your eyes. Different lenses have different coatings and tints.

Also read:5 Nutrients You Should Not Miss To Maintain Healthy Eyesight

You should also describe other discomforts you are facing while working. Many experience irritation or dry eye. Your doctor may prescribe eye drops to address the issues.

Use eye drop if required to fight discomfortPhoto Credit: iStock

When you are working, you take a break and start using your phone. In this process, you do not give your eye the required break. During a break make sure that you do not use any kind of screens.

Promoted

Also read:How To Manage Dry Eyes Naturally?

Disclaimer: This content including advice provides generic information only. It is in no way a substitute for qualified medical opinion. Always consult a specialist or your own doctor for more information. NDTV does not claim responsibility for this information.

DoctorNDTV is the one stop site for all your health needs providing the most credible health information, health news and tips with expert advice on healthy living, diet plans, informative videos etc. You can get the most relevant and accurate info you need about health problems like diabetes, cancer, pregnancy, HIV and AIDS, weight loss and many other lifestyle diseases. We have a panel of over 350 experts who help us develop content by giving their valuable inputs and bringing to us the latest in the world of healthcare.

Originally posted here:
Experiencing Eye Strain Too Often? Here Are Some Prevention Tips That Might Help - Doctor NDTV

He wasn't going to let losing his sight stop him doing the Great North Run.

So this dedicated runner certainly isn't going to let a pandemic get in the way.

The Great North Run may have been cancelled as a result of Covid-19, but Gary Ferguson, from Rowlands Gill, is among the hundreds of people who are finding a new way to test their bodies and raise money for charity, just as they planned to do in the famous half marathon.

Civil servant Gary, 59, has reached the finish line of the famous Newcastle - South Shields course around 13 times before, but this year was set to be an extra challenge.

Though he's had serious eye problems for most of his life, this was to be his first time completing the run since he eyesight deteriorate to the point where he could no longer run safely without a guide, and has applied for a guide dog.

Undeterred, Gary, who is registered blind, decided to raise cash for others in his position, running to collect sponsorship for the Guide Dogs charity, as well as the NHS.

He's now completing the Great North Run solo challenge instead: completing 40 runs over the 78 days leading up to September 13, when the half marathon should have taken place.

On the day itself, Gary and his guide runner, Craig Merrick, will be running 13.1miles along the Derwent Walk from Rowlands Gill, with Gary in a 'Braveheart' costume, an outfit he's often used in the Great North Run.

He said: "It would have been the first time I'd run it with my eyes this bad, and I was looking forward to it, because having applied for a guide dog myself I wanted to get the chance to support and raise money for them.

"It was disappointing when Covid-19 knocked it all back: it's frustrating for everybody who was going to run, but it's the charities who really suffer, because they are losing millions that they would have got in sponsorship."

Running while blind is not without its challenges, and Gary has been forced to adapt to a whole new way of doing the sport he loves, due to the cloudy cornea which makes the world around him dark and his vision 'like being in a steamy sauna'.

"It's frustrating, more than anything. Usually I like to dictate the pace, but now I have to run right behind my guide: they run right in front of me wearing a high-visibility tabard and that's about as far as I can see," he explained.

"Sometimes, depending on the weather, if the sun is shining through the trees, for example, the person I'm running behind tends to disappear, so some of the time I am literally running blind, hoping there's nothing going to hit me before that little bit of visibility comes back."

He's spurred on by his love of running outdoors, as well as a desire to help others who've lost their sight, as he knows from experience how valuable a guide dog can be.

He said: "I've been approved for a dog and I'm on a waiting list, but it's a long list because there are a lot of people needing it.

"It's about independence: at the moment I'm having to depend on other people for small things, like going to the shops, with a dog, I could do that on my own."

Gary is raising money for Guide Dogs and the NHS at https://justgiving.com/fundraising/gary-ferguson6

Read more here:
Blind Gateshead runner won't let sight loss or the pandemic stop him completing the Great North Run - Chronicle Live

Bionic Eye Market

Los Angeles, United State,- This research study is one of the most detailed and accurate ones that solely focus on the global Bionic Eye market. It sheds light on critical factors that impact the growth of the global Bionic Eye market on several fronts. Market participants can use the report to gain a sound understanding of the competitive landscape and strategies adopted by leading players of the global Bionic Eye market. The authors of the report segment the globalBionic Eyemarket according to a type of product, application, and region. The segments studied in the report are analyzed on the basis of market share, consumption, production, market attractiveness, and other vital factors.

The geographical analysis of the global Bionic Eye market provided in the research study is an intelligent tool that interested parties can use to identify lucrative regional markets. It helps readers to become aware of the characteristics of different regional markets and how they are progressing in terms of growth. The report also offers a deep analysis of Bionic Eye market dynamics, including drivers, challenges, restraints, trends and opportunities, and market influence factors. It provides a statistical analysis of the global Bionic Eye market, which includes CAGR, revenue, volume, market shares, and other important figures. On the whole, it comes out as a complete package of various market intelligence studies focusing on the global Bionic Eye market.

Get PDF template of this report:https://www.qyresearch.com/sample-form/form/1537213/global-bionic-eye-market

Company Profiles: It is a very important section of the report that includes accurate and deep profiling of leading players of the global Bionic Eye market. It provides information about the main business, markets served, gross margin, revenue, price, production, and other factors that define the market progress of players studied in the Bionic Eye report.

Major Players Cited in the Report

Retina Implant AG, Bionic Vision Australia, THE BIONIC EYE, Pixium Vision, iBionics, Second Sight Medical Products, NeoStrata Company, ABIOMED, Berlin Heart, Zimmer Biomet, etc.

Global Bionic Eye Market Size Estimation

In order to estimate and validate the size of the global Bionic Eye market, our researchers used bottom-up as well as top-down approaches. These methods were also used to project the Bionic Eye market size of segments and sub-segments included in the report.

We used secondary sources to determine all breakdowns, splits, and percentage shares and completed their verification with the help of primary sources. We used both primary and secondary research processes to estimate the global Bionic Eye market size vis--vis value and analyze the supply chain of the industry. In addition, extensive secondary research was conducted to identify key players in the global Bionic Eye market.

Global Bionic Eye Market by Product

Electronic, Mechanical

Global Bionic Eye Market by Application

Hospitals, Clinics, Others Global Bionic Eye Market: Regional Analysis The report offers in-depth assessment of the growth and other aspects of the Bionic Eye market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region. Global Bionic Eye Market: Competitive Landscape This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and production by manufacturers during the forecast period of 2015 to 2019. The major players in the market include Retina Implant AG, Bionic Vision Australia, THE BIONIC EYE, Pixium Vision, iBionics, Second Sight Medical Products, NeoStrata Company, ABIOMED, Berlin Heart, Zimmer Biomet, etc.

Report Objectives

Tracking and analyzing competitive developments in the global Bionic Eye market, including research and development, merger and acquisition, collaboration, and product launch Analyzing core competencies and market shares of leading companies in a comprehensive manner Forecasting the growth of the overall global Bionic Eye market and its important segments on the basis of revenue and volume Pinpointing market opportunities for stakeholders, vendors, market players, and other interested parties Strategically analyzing microeconomic and macroeconomic factors and their influence on future prospects and growth trends of the global Bionic Eye market

Enquire for customization in Report @https://www.qyresearch.com/customize-request/form/1537213/global-bionic-eye-market

TOC

Table of Contents 1 Bionic Eye Market Overview1.1 Product Overview and Scope of Bionic Eye1.2 Bionic Eye Segment by Type1.2.1 Global Bionic Eye Production Growth Rate Comparison by Type 2020 VS 20261.2.2 Electronic1.2.3 Mechanical1.3 Bionic Eye Segment by Application1.3.1 Bionic Eye Consumption Comparison by Application: 2020 VS 20261.3.2 Hospitals1.3.3 Clinics1.3.4 Others1.4 Global Bionic Eye Market by Region1.4.1 Global Bionic Eye Market Size Estimates and Forecasts by Region: 2020 VS 20261.4.2 North America Estimates and Forecasts (2015-2026)1.4.3 Europe Estimates and Forecasts (2015-2026)1.4.4 China Estimates and Forecasts (2015-2026)1.4.5 Japan Estimates and Forecasts (2015-2026)1.4.6 South Korea Estimates and Forecasts (2015-2026)1.5 Global Bionic Eye Growth Prospects1.5.1 Global Bionic Eye Revenue Estimates and Forecasts (2015-2026)1.5.2 Global Bionic Eye Production Capacity Estimates and Forecasts (2015-2026)1.5.3 Global Bionic Eye Production Estimates and Forecasts (2015-2026) 2 Market Competition by Manufacturers2.1 Global Bionic Eye Production Capacity Market Share by Manufacturers (2015-2020)2.2 Global Bionic Eye Revenue Share by Manufacturers (2015-2020)2.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)2.4 Global Bionic Eye Average Price by Manufacturers (2015-2020)2.5 Manufacturers Bionic Eye Production Sites, Area Served, Product Types2.6 Bionic Eye Market Competitive Situation and Trends2.6.1 Bionic Eye Market Concentration Rate2.6.2 Global Top 3 and Top 5 Players Market Share by Revenue2.6.3 Mergers & Acquisitions, Expansion 3 Production Capacity by Region3.1 Global Production Capacity of Bionic Eye Market Share by Regions (2015-2020)3.2 Global Bionic Eye Revenue Market Share by Regions (2015-2020)3.3 Global Bionic Eye Production Capacity, Revenue, Price and Gross Margin (2015-2020)3.4 North America Bionic Eye Production3.4.1 North America Bionic Eye Production Growth Rate (2015-2020)3.4.2 North America Bionic Eye Production Capacity, Revenue, Price and Gross Margin (2015-2020)3.5 Europe Bionic Eye Production3.5.1 Europe Bionic Eye Production Growth Rate (2015-2020)3.5.2 Europe Bionic Eye Production Capacity, Revenue, Price and Gross Margin (2015-2020)3.6 China Bionic Eye Production3.6.1 China Bionic Eye Production Growth Rate (2015-2020)3.6.2 China Bionic Eye Production Capacity, Revenue, Price and Gross Margin (2015-2020)3.7 Japan Bionic Eye Production3.7.1 Japan Bionic Eye Production Growth Rate (2015-2020)3.7.2 Japan Bionic Eye Production Capacity, Revenue, Price and Gross Margin (2015-2020)3.8 South Korea Bionic Eye Production3.8.1 South Korea Bionic Eye Production Growth Rate (2015-2020)3.8.2 South Korea Bionic Eye Production Capacity, Revenue, Price and Gross Margin (2015-2020) 4 Global Bionic Eye Consumption by Regions4.1 Global Bionic Eye Consumption by Regions4.1.1 Global Bionic Eye Consumption by Region4.1.2 Global Bionic Eye Consumption Market Share by Region4.2 North America4.2.1 North America Bionic Eye Consumption by Countries4.2.2 U.S.4.2.3 Canada4.3 Europe4.3.1 Europe Bionic Eye Consumption by Countries4.3.2 Germany4.3.3 France4.3.4 U.K.4.3.5 Italy4.3.6 Russia4.4 Asia Pacific4.4.1 Asia Pacific Bionic Eye Consumption by Region4.4.2 China4.4.3 Japan4.4.4 South Korea4.4.5 Taiwan4.4.6 Southeast Asia4.4.7 India4.4.8 Australia4.5 Latin America4.5.1 Latin America Bionic Eye Consumption by Countries4.5.2 Mexico4.5.3 Brazil 5 Production, Revenue, Price Trend by Type5.1 Global Bionic Eye Production Market Share by Type (2015-2020)5.2 Global Bionic Eye Revenue Market Share by Type (2015-2020)5.3 Global Bionic Eye Price by Type (2015-2020)5.4 Global Bionic Eye Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 6 Global Bionic Eye Market Analysis by Application6.1 Global Bionic Eye Consumption Market Share by Application (2015-2020)6.2 Global Bionic Eye Consumption Growth Rate by Application (2015-2020) 7 Company Profiles and Key Figures in Bionic Eye Business7.1 Retina Implant AG7.1.1 Retina Implant AG Bionic Eye Production Sites and Area Served7.1.2 Retina Implant AG Bionic Eye Product Introduction, Application and Specification7.1.3 Retina Implant AG Bionic Eye Production Capacity, Revenue, Price and Gross Margin (2015-2020)7.1.4 Retina Implant AG Main Business and Markets Served7.2 Bionic Vision Australia7.2.1 Bionic Vision Australia Bionic Eye Production Sites and Area Served7.2.2 Bionic Vision Australia Bionic Eye Product Introduction, Application and Specification7.2.3 Bionic Vision Australia Bionic Eye Production Capacity, Revenue, Price and Gross Margin (2015-2020)7.2.4 Bionic Vision Australia Main Business and Markets Served7.3 THE BIONIC EYE7.3.1 THE BIONIC EYE Bionic Eye Production Sites and Area Served7.3.2 THE BIONIC EYE Bionic Eye Product Introduction, Application and Specification7.3.3 THE BIONIC EYE Bionic Eye Production Capacity, Revenue, Price and Gross Margin (2015-2020)7.3.4 THE BIONIC EYE Main Business and Markets Served7.4 Pixium Vision7.4.1 Pixium Vision Bionic Eye Production Sites and Area Served7.4.2 Pixium Vision Bionic Eye Product Introduction, Application and Specification7.4.3 Pixium Vision Bionic Eye Production Capacity, Revenue, Price and Gross Margin (2015-2020)7.4.4 Pixium Vision Main Business and Markets Served7.5 iBionics7.5.1 iBionics Bionic Eye Production Sites and Area Served7.5.2 iBionics Bionic Eye Product Introduction, Application and Specification7.5.3 iBionics Bionic Eye Production Capacity, Revenue, Price and Gross Margin (2015-2020)7.5.4 iBionics Main Business and Markets Served7.6 Second Sight Medical Products7.6.1 Second Sight Medical Products Bionic Eye Production Sites and Area Served7.6.2 Second Sight Medical Products Bionic Eye Product Introduction, Application and Specification7.6.3 Second Sight Medical Products Bionic Eye Production Capacity, Revenue, Price and Gross Margin (2015-2020)7.6.4 Second Sight Medical Products Main Business and Markets Served7.7 NeoStrata Company7.7.1 NeoStrata Company Bionic Eye Production Sites and Area Served7.7.2 NeoStrata Company Bionic Eye Product Introduction, Application and Specification7.7.3 NeoStrata Company Bionic Eye Production Capacity, Revenue, Price and Gross Margin (2015-2020)7.7.4 NeoStrata Company Main Business and Markets Served7.8 ABIOMED7.8.1 ABIOMED Bionic Eye Production Sites and Area Served7.8.2 ABIOMED Bionic Eye Product Introduction, Application and Specification7.8.3 ABIOMED Bionic Eye Production Capacity, Revenue, Price and Gross Margin (2015-2020)7.8.4 ABIOMED Main Business and Markets Served7.9 Berlin Heart7.9.1 Berlin Heart Bionic Eye Production Sites and Area Served7.9.2 Berlin Heart Bionic Eye Product Introduction, Application and Specification7.9.3 Berlin Heart Bionic Eye Production Capacity, Revenue, Price and Gross Margin (2015-2020)7.9.4 Berlin Heart Main Business and Markets Served7.10 Zimmer Biomet7.10.1 Zimmer Biomet Bionic Eye Production Sites and Area Served7.10.2 Zimmer Biomet Bionic Eye Product Introduction, Application and Specification7.10.3 Zimmer Biomet Bionic Eye Production Capacity, Revenue, Price and Gross Margin (2015-2020)7.10.4 Zimmer Biomet Main Business and Markets Served 8 Bionic Eye Manufacturing Cost Analysis8.1 Bionic Eye Key Raw Materials Analysis8.1.1 Key Raw Materials8.1.2 Key Raw Materials Price Trend8.1.3 Key Suppliers of Raw Materials8.2 Proportion of Manufacturing Cost Structure8.3 Manufacturing Process Analysis of Bionic Eye8.4 Bionic Eye Industrial Chain Analysis 9 Marketing Channel, Distributors and Customers9.1 Marketing Channel9.2 Bionic Eye Distributors List9.3 Bionic Eye Customers 10 Market Dynamics10.1 Market Trends10.2 Opportunities and Drivers10.3 Challenges10.4 Porters Five Forces Analysis 11 Production and Supply Forecast11.1 Global Forecasted Production of Bionic Eye (2021-2026)11.2 Global Forecasted Revenue of Bionic Eye (2021-2026)11.3 Global Forecasted Price of Bionic Eye (2021-2026)11.4 Global Bionic Eye Production Forecast by Regions (2021-2026)11.4.1 North America Bionic Eye Production, Revenue Forecast (2021-2026)11.4.2 Europe Bionic Eye Production, Revenue Forecast (2021-2026)11.4.3 China Bionic Eye Production, Revenue Forecast (2021-2026)11.4.4 Japan Bionic Eye Production, Revenue Forecast (2021-2026)11.4.5 South Korea Bionic Eye Production, Revenue Forecast (2021-2026) 12 Consumption and Demand Forecast12.1 Global Forecasted and Consumption Demand Analysis of Bionic Eye12.2 North America Forecasted Consumption of Bionic Eye by Country12.3 Europe Market Forecasted Consumption of Bionic Eye by Country12.4 Asia Pacific Market Forecasted Consumption of Bionic Eye by Regions12.5 Latin America Forecasted Consumption of Bionic Eye 13 Forecast by Type and by Application (2021-2026)13.1 Global Production, Revenue and Price Forecast by Type (2021-2026)13.1.1 Global Forecasted Production of Bionic Eye by Type (2021-2026)13.1.2 Global Forecasted Revenue of Bionic Eye by Type (2021-2026)13.1.2 Global Forecasted Price of Bionic Eye by Type (2021-2026)13.2 Global Forecasted Consumption of Bionic Eye by Application (2021-2026) 14 Research Finding and Conclusion 15 Methodology and Data Source15.1 Methodology/Research Approach15.1.1 Research Programs/Design15.1.2 Market Size Estimation15.1.3 Market Breakdown and Data Triangulation15.2 Data Source15.2.1 Secondary Sources15.2.2 Primary Sources15.3 Author List15.4 Disclaimer

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become a brand of quality assurance in the consulting industry.

Read more here:
Bionic Eye Market Challenges and Growth Factor By 2026| Bionic Vision Australia, THE BIONIC EYE, Pixium Vision - Weekly Wall

DUBLIN--(BUSINESS WIRE)--The "Phoropters Market - Growth, Trends, and Forecast (2020-2025)" report has been added to ResearchAndMarkets.com's offering.

The global Phoropters market is anticipated to grow with a CAGR of nearly 4.1%, during the forecast period.

Certain factors that are driving the market growth include growing prevalence and recurrence of eye disorders and technological advancements.

In many developed and developing nations, eye disorders have emerged as potential threats to the status of sight of their people. The significant rise in the prevalence of diabetes in various countries has led to diabetic retinopathy being added to the priority list.

According to the WHO, in 2018, it was estimated that approximately 1.3 billion people were living with some form of vision impairment, 188.5 million people had mild vision impairment, 217 million had moderate to severe vision impairment, and 36 million people are blind.

Across the globe, the leading causes of vision impairment are uncorrected refractive errors and cataracts, and most people with vision impairment are over the age of 50 years. As per the WHO, chronic eye diseases are the number one cause of vision loss, with the top two causes being unoperated cataracts and uncorrected refractive errors. The former is the leading cause in countries with low- or middle-incomes.

In addition, the global geriatric population continues to grow at an unprecedented rate. The increase in the aging population presents several public health challenges that people need to prepare for. Presbyopia is an age-related visual impairment. It results from the gradual decrease in accommodation expected with age and can have multiple effects on quality of vision and quality of life. Though not incapacitating if corrected, presbyopia without optical correction results in an inability to perform once-effortless near tasks at a customary working distance without experiencing visual symptoms.

Hence, the rising incidence of eye-related disorders is projecting a great impact on the growth of market studied.

Key Market Trends

Specialty Clinics Hold Significant Share

Specialty clinics are expected to observe a steady growth in adoption rate of phoropters, owing to the increasing number of eye disorders. For instance, the prevalence of presbyopia is higher in societies in which larger proportions of the population survive into old age. With the aging of the U.S. population, unprecedented number of patients with presbyopia can be expected to present to optometrists' offices in the coming years.

Because presbyopia is age related, its prevalence is directly related to the proportion of older persons in the population. Although it is difficult to estimate the incidence of a chronic condition such as presbyopia, due to its slow onset, it appears that the highest incidence of presbyopia (i.e., first-reported effects) is in people aged 42 to 44 years. Hence, with the emergence of such diseases, specialty clinics are gaining attention in the market studied.

North America Dominates the Global Market

In the North American region, the United States accounted for the largest market share. According to the 2018 report of the American Optometric Association, Myopia affects nearly 30 percent of the U.S. population.

While the exact cause of myopia is unknown, there is significant evidence that many people inherit myopia, or at least the tendency to develop myopia. If one or both parents are nearsighted, there is an increased chance their children will be nearsighted.

A study conducted for the year 2016-2017 estimated that 9.6 million adults in the United States are highly myopic, or severely nearsighted. Of those, nearly 820,000 have a degenerative form of the disease and more than 41,000 suffer a complication called myopic choroidal neovascularization that could cause long-term vision loss, with women at higher risk. The findings were published in the Journal of the American Academy of Ophthalmology.

Competitive Landscape

The global Phoropters market is moderately competitive and consists of a few major players. There is a presence of local as well as international companies in the global market. Some of the key players include Briot USA Inc., Huvitz Co. Ltd., Marco, Nidek, Reichert Inc., Rexxam Co. Ltd., Carl Zeiss AG, among others.

Key Topics Covered

1 INTRODUCTION

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Growing Prevalence and Recurrence of Eye Disorders

4.2.2 Technological Advancements

4.3 Market Restraints

4.3.1 High Installation Cost and Lack of Skilled Optometrists

4.4 Porter's Five Force Analysis

5 MARKET SEGMENTATION

5.1 By Type

5.1.1 Manual

5.1.2 Digital

5.2 By End-user

5.2.1 Hospitals

5.2.2 Specialty Clinics

5.2.3 Others

5.3 Geography

5.3.1 North America

5.3.2 Europe

5.3.3 Asia-Pacific

5.3.4 Middle-East and Africa

5.3.5 South America

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

6.1.1 Briot USA Inc.

6.1.2 Huvitz Co. Ltd.

6.1.3 Marco

6.1.4 NIDEK Co. Ltd.

6.1.5 Reichert, Inc.

6.1.6 Rexxam Co. Ltd.

6.1.7 Righton Limited

6.1.8 Topcon Corporation

6.1.9 Carl Zeiss AG

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit https://www.researchandmarkets.com/r/k48c65

Read the original:
Global Phoropters Market Forecast 2020-2025 with Profiles of Major Players Briot USA, Huvitz, Marco, NIDEK, and Reichert Among Others -...

Overview Of Eyesight Test Equipment Industry 2020-2025:

This has brought along several changes in This report also covers the impact of COVID-19 on the global market.

The Eyesight Test Equipment Market analysis summary by Reports Insights is a thorough study of the current trends leading to this vertical trend in various regions. Research summarizes important details related to market share, market size, applications, statistics and sales. In addition, this study emphasizes thorough competition analysis on market prospects, especially growth strategies that market experts claim.

Eyesight Test Equipment Market competition by top manufacturers as follow: , EyeNetra, Bhavana MDC, Essilor International, Alcon, Inc., Heine, Heidelberg Engineering GmbH, Seiko Optical Products Co., Ltd., Nidek Co., Ltd., Carl Zeiss AG, Hoya Corporation, Abbott Medical Optics.Inc., Johnson & Johnson Vision Care.Inc., Shenzhen Certainn Technology

Get a Sample PDF copy of the report @ https://reportsinsights.com/sample/67174

The global Eyesight Test Equipment market has been segmented on the basis of technology, product type, application, distribution channel, end-user, and industry vertical, along with the geography, delivering valuable insights.

The Type Coverage in the Market are: PortableStationary

Market Segment by Applications, covers:ChildrenAdultsThe Elder

Market segment by Regions/Countries, this report coversNorth AmericaEuropeChinaRest of Asia PacificCentral & South AmericaMiddle East & Africa

Major factors covered in the report:

To get this report at a profitable rate.: https://reportsinsights.com/discount/67174

The analysis objectives of the report are:

Access full Report Description, TOC, Table of Figure, Chart, [emailprotected] https://reportsinsights.com/industry-forecast/Eyesight-Test-Equipment-Market-67174

About US:

Reports Insights is the leading research industry that offers contextual and data-centric research services to its customers across the globe. The firm assists its clients to strategize business policies and accomplish sustainable growth in their respective market domain. The industry provides consulting services, syndicated research reports, and customized research reports.

Contact US:

:(US) +1-214-272-0234

:(APAC) +91-7972263819

Email:[emailprotected]

Sales:[emailprotected]

View original post here:
New Comprehensive Report on Eyesight Test Equipment Market to Witness an Outstanding Growth during 2020 2025 with Top Players Like EyeNetra, Bhavana...

FORT MYERS

With online learning, most kids are experiencing an increase in screen time, and that can mean tired and itchy eyes.

A local eye doctor says the blue-light-blocking glasses actually improve your eyesight by about seven percent when looking at your phone, a computer screen, or a television.

Making it more effective than simply dimming down the brightness.

You see details more clearly so you will be able to resolve letters easier so that makes you work less, so you feel less fatigued. What happens when you dim down the screen intensity, you dont see the contrast as well so you cant see details as well and the result of that is you get more fatigued from your computer, said Dr. Richard Mauer, who works at the Eye Center of Florida.

Mauer says blue light blocking treatment on eyeglass lenses can be as cheap as $30 depending on your vision plan.

Amazon sells nonprescription glasses for as little as $13.

An option that appealed to Megan Tripp, a mother of two who has concerns about long terms impacts the increased screen time could have on her children.

He has more headaches, hes grumpier, its harder for him to break away from whats in front of that screen or what is reality, Tripp said.

Megan says its also important to give your kids a break from the computer. Thats why after a couple of hours of work she takes them outside for some natural light and fresh air.

Original post:
Parents worry too much screen time will have an adverse affect on children's vision - Wink News

Chrissy Suttles| csuttles@timesonline.com

AMBRIDGE Mindy Reynolds niece, Andy, will be learning remotely this fall as COVID-19 concerns remain high in her family and throughout the region.

One of her first thoughts while registering Andy for online learning was possible vision strain. Her prescription lenses are several years old, and more screen time could further hurt her eyesight.

An estimated 30,000 children in southwestern Pennsylvania lack access to proper vision care, according to the nonprofit Vision to Learn. The organization provides free eye exams and glasses to kids in high-need communities via a mobile clinic.

On Wednesday, the group stopped at Good Samaritan Catholic Church in Ambridge to give 18 youngsters in Beaver County new glasses ahead of the school year.

Shes so excited, Reynolds said. Things have been rough for a lot of families lately, so this is one easy win.

Vision to Learn has served about 280,000 kids nationwide since 2012, and about 5,000 in the Pittsburgh region since launching locally two years ago.

Wednesdays visit was their first stop in Beaver County, although the group will be partnering with Aliquippa schools this year to serve even more students; Vision to Learn partners with more than 20 school districts in the region.

Mobile clinics are equipped with self-contained optometric exam lanes with licensed optometrists. If students glasses are lost or broken, Vision to Learn replaces them for free within a year.

Its amazing to see a kid who is able to see clearly for the first time, said Vision to Learn program director Mark Scaramuzzi. For a lot of kids, they don't know they cant see. They don't know their vision is poor because its the way they've always seen. Its incredibly rewarding.

In western Pennsylvania, transportation is a significant barrier to families receiving proper care, he said, alongside low income and lack of insurance. Local staff members have traveled from New Castle to Washington, and everywhere in between, to help as many local families as possible.

We see kids on a daily basis, and sometimes its been multiple years since their glasses were broken and not replaced, Scaramuzzi said. You see kids who, in a lot of cases, have never had glasses and have very poor eyesight.

Since the start of COVID-19, staff has modified protocols to ensure social distancing. Only one child at a time can be seen at the clinic, and stations are thoroughly cleaned between each patient.

But summertime allows the group to see a greater variety of children before returning to schools in the fall.

If you cant see, you cant learn, Scaramuzzi said. And, particularly, in light of all the issues going on with COVID, were seeing more demand than ever.

Originally posted here:
Vision to Learn helps Beaver County students see for free - The Times

Open-angle glaucoma is a disease of the eye that can slowly and painlessly cause permanent loss of vision. It rarely causes any symptoms until its in an advanced stage, which is why its known as the silent thief of sight.

Glaucoma is a leading cause of irreversible blindness in the world. If you have risk factors, being proactive and getting your eyes checked is incredibly important. Your ophthalmologist can spot the signs of early glaucoma and help stop vision loss.

So what exactly is glaucoma?

Glaucoma is a progressive disease of the optic nerve when the pressure in the eye is higher than the nerve can tolerate. Patients begin to lose their peripheral vision and over time this progresses inward. Patients with glaucoma rarely have complaints until the disease has advanced to the center of their vision; however, it is often too late to help at that point because the damage is not reversible. With early diagnosis by an eye doctor, there are many treatments available to stop glaucoma from advancing.

What can cause open-angle glaucoma?

The nerve damage in glaucoma in most cases is due to an increased pressure in the eye. Pressure levels vary for each patient and even throughout the day. Pressure is maintained by aqueous humor or fluid in the eye that is constantly produced by a tiny gland in the eye the ciliary body. This fluid flows between the iris and the lens, then out of the eye through a very small drain called the trabecular meshwork. Pressure in the eye is elevated for two main reasons: The trabecular meshwork drain is clogged and enough fluid doesnt leave the eye, or the ciliary body produces too much fluid. This elevated pressure typically does not cause any symptoms and will silently damage the nerve.

Whos at risk of developing Glaucoma?

Anyone can get glaucoma; however, some individuals are at higher risk for developing glaucoma. Those at highest risk are African American patients over the age of 50, Hispanic patients over the age of 65, patients with a family history of glaucoma and patients with diabetes. Medicare recommends to have yearly screenings for patients who fall under any of these high-risk groups in order to catch the disease at its earliest state.

How to check for glaucoma

Thanks to advances in medicine, we have the ability to diagnose glaucoma earlier and more accurately. A typical evaluation includes a comprehensive eye exam where an eye doctor analyzes the nerve for damage and measures the pressure in the eye, which should range between 8 and 21 mmHg. Additionally, there are two other tests performed to accurately diagnose if you have the disease and what stage. First, an OCT nerve scan is used to detect subtle thinning/damage of the nerve. Secondly, a visual field is performed to test for areas of missing vision.

How is glaucoma treated?

When diagnosed and treatment has begun, it is a lifelong disease that will require continuous management. We can control or slow the progression, but unfortunately cannot reverse or cure glaucoma. There are many eye drops available and, depending on the severity, more than one medication may be needed. If glaucoma cant be controlled with medications, other procedures such as laser or surgery may be considered.

For more information about glaucoma or any eye disease, call Dr. Jhaj at his office directly at 442-255-4012.

Read the original post:
My Health, My Choice: Glaucoma, the silent thief of sight - VVdailypress.com

Global Eye Health Ingredients Market: Overview

Toxic impurities in contact with eyes cause adverse effects on eyesight leading to unhealthy vision. Antioxidants such as Lutein and Zeaxanthin of the carotenoid family are some of the eye health ingredients. Use of antioxidants as eye health ingredients is expected to grow steadily over the forecast period. Increase in number of eye health supplements is also projected to enhance the growth of eye health ingredients market during the forecast period. In addition, protection from UV radiation, elimination of free radicals, need for powerful vision, and high demand for vision sustenance are some of the prominent factors driving the eye health ingredients market.

Request For Report [emailprotected]https://www.trendsmarketresearch.com/report/sample/3633

Increasing eye health problems including cataract, glaucoma, diabetic retinopathy, and Age-Related Macular Degeneration (AMD) are expected to fuel the growth of the global eye health ingredient market. Also, large spending on nutritional products has influenced the pharmaceutical industry growth. Increasing exposure to digital displays, rising prevalence of allergies, and changing lifestyle have resulted in more eye diseases, which, in turn, is projected to bolster the growth of global eye health ingredients market.Eye Health Ingredients Market size was worth over USD xx million in 2018 and is set to exceed 1.8 kilo tons by 2025.

Some of the key players involved in the global eye health ingredients market are Amway, MacuShield, Bausch & Lomb Incorporated, Novartis AG, Solgar Inc., Swanson Health Products, Allied Biotech Corporation, BASF SE, DSM, Kemin Industries Inc., Davos Life Science Pte ltd., Wilmar International Limited, and Vitae Naturals.

Global Eye Health IngredientsMarket: Segmentation

By Source Type

Natural SourcesSynthetic SourcesBy Ingredient Type

LuteinZeaxanthinVitamin ABeta-caroteneBilberry extractsForm Type

Get Complete TOC with Tables and [emailprotected]https://www.trendsmarketresearch.com/report/discount/3633

PowderLiquidOthers (Capsule, Soft Gels, Tablets)By Application:

HumanAnimalBy Disease Indication

CataractAge related Macular Degeneration (AMD)Dry Eye SyndromeOthers

Natural source segment accounted for the largest market share in the global eye health ingredients market in 2017. The growing consumer awareness regarding benefits of natural health sources is expected to fuel the demand for natural eye health ingredients. Lutein and zeaxanthin, the most commonly used ingredients, are usually combined with other health beneficial components such as vitamins A, C, B, and minerals such as zinc and selenium.

North America is expected to be the most lucrative market for eye health ingredients followed by Europe and Asia Pacific. Increasing incidence of low vision and blindness among the people in North America has led to an increased demand for eye health ingredients. Rising geriatric population coupled with increasing consumer spending on healthcare, preference toward healthy lifestyle, and factors such as occupational hazards and smoking, which cause eye-related diseases, are expected to propel the growth of eye health ingredients market globally during the forecast period. The Food and Drug Administration (FDA) does not recommend a safe upper limit for eye health ingredients such as lutein, zeaxanthin, beta carotene, and bilberry extract, making consumers apprehensive about the dosage levels in both functional foods and dietary supplements. Technological advancements and innovations put forth by the manufacturers to expand their portfolio are expected to augment the market growth.

<<>>https://www.trendsmarketresearch.com/report/covid-19-analysis/3633

In February 2016, Waitaki Biosciences, one of the key manufacturers of natural nutritional products, launched CassiPure, anthocyanin rich blackcurrant extracts for eye health and immune support. Similarly, in July 2016, Nestle Taiwan launched upgraded Nestle Good Health Nutrition product for eye health among the middle-aged population, particularly for those who spend several hours a day using smart phones.

Read the original:
Eye Health Ingredients Market 2018 2025 What Recent Study Say About Top Companies | Trends Market Research - eRealty Express

LONDON--(BUSINESS WIRE)--Gyroscope Therapeutics Limited, a clinical-stage retinal gene therapy company, today announced the initiation of its Phase II programme evaluating its investigational gene therapy, GT005, for the treatment of geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD). Dry AMD is a leading cause of permanent vision loss in people over the age of 50. GT005 is a one-time AAV-based gene therapy that is delivered under the retina. The goal of the Phase II clinical trial programme is to determine if GT005 has the potential to slow the progression of GA.

Gyroscope plans to conduct two Phase II trials evaluating GT005 in people with GA. The first, called EXPLORE, is enrolling people who have a mutation in their Complement Factor I (CFI) gene [NCT04437368]. The first patient to receive GT005 in EXPLORE was enrolled and dosed by Dr. Arshad M. Khanani at Sierra Eye Associates in Reno, Nev., USA.

Geographic atrophy is a devastating diagnosis, as there are no approved treatments for this gradual and irreversible loss of vision, said Arshad M. Khanani, M.D., M.A., Director of Clinical Research at Sierra Eye Associates and Clinical Associate Professor at the University of Nevada, Reno School of Medicine, and an investigator in the EXPLORE trial. We are excited to participate in this trial evaluating GT005 for the potential to slow progression of geographic atrophy. We believe one-time gene therapies could be a major advancement in the field of retinal disease.

GT005 is designed to restore balance to an overactive complement system, a part of the immune system, by increasing production of the CFI protein. An overactive complement system has been implicated in the development of AMD. The CFI protein regulates the activity of the complement system. It is believed that increasing CFI production will dampen the systems overactivity and reduce inflammation, with the goal of preserving a persons eyesight.

Research has found that approximately 3% of people with dry AMD have certain CFI mutations that correlate with low CFI levels in the blood and a higher risk of developing AMD.1 Gyroscope estimates that more than 100,000 people with GA in the United States and EU5 European countries may have these mutations.1,2,3,4 The EXPLORE trial will evaluate GT005 in this group of people with mutations in their CFI gene.

Research has also shown that a small supplementation of CFI can normalise complement activity in the blood,5 suggesting GT005 may also be applicable for a broader group of people with GA. It is estimated that approximately one million people in the United States alone have GA.4 Gyroscope therefore plans to initiate a second Phase II trial in 2020 that will evaluate GT005 in a broader GA population.

We are excited about the potential of GT005 for people with dry AMD. Research suggests GT005 may be best suited for people with certain mutations in their CFI gene. However, evidence also suggests it may have potential for a broader population of people with geographic atrophy, said Nadia Waheed, M.D., MPH, Chief Medical Officer of Gyroscope. We have designed our clinical programme to evaluate these groups in two distinct Phase II trials, with the goal of determining which patients GT005 may be most appropriate for and to further our understanding of the role of the complement system in AMD.

About the EXPLORE Trial

EXPLORE is a Phase II, multicentre, randomised trial evaluating the safety and efficacy of GT005 administered as a single subretinal injection.

EXPLORE is enrolling people who are aged 55 or older and have a clinical diagnosis of GA secondary to dry AMD and who have a mutation of the CFI gene. People being screened for the trial will be genotyped for the mutations. Trial participants will be randomised to one of three treatment arms: GT005 dose 1, GT005 dose 2 or a control arm. Participants in the control arm will receive current standard of care. The primary endpoint of EXPLORE is progression of GA over 48 weeks. The study will also evaluate GT005 for various safety and tolerability measures. Gyroscope plans to enroll approximately 75 patients at approximately 40 centres based in the United States, United Kingdom, Europe and Australia.

Gyroscope will announce details about the second Phase II trial of GT005 at a later date.

About Age-Related Macular Degeneration (AMD) and Geographic Atrophy (GA)

AMD is a leading cause of blindness affecting an estimated 196 million people globally.6 AMD typically affects people aged 50 and older, and causes a gradual and permanent loss of central vision that worsens over time.7 There are no approved treatments for the dry form of AMD, which is the most common, impacting approximately 90% of people with the disease.8 As dry AMD advances it leads to GA, an irreversible degeneration of retinal cells. This vision loss can be devastating, severely impacting a persons daily life as they lose the ability to drive, read and even see the faces of loved ones.

About Gyroscope Therapeutics: Vision for Life

Gyroscope Therapeutics is a clinical-stage retinal gene therapy company developing and delivering gene therapy beyond rare disease to treat a leading cause of blindness, dry AMD. Our lead investigational gene therapy, GT005, is a one-time therapy delivered under the retina. GT005 is designed to restore balance to an overactive complement system by increasing production of the Complement Factor I protein. GT005 is currently being evaluated in a Phase I/II clinical trial called FOCUS and a Phase II clinical trial called EXPLORE.

Syncona Ltd, our lead investor, helped us create the only retinal gene therapy company to combine discovery, research, drug development, a manufacturing platform and surgical delivery capabilities. Headquartered in London with locations in Philadelphia and San Francisco, our mission is to preserve sight and fight the devastating impact of blindness. For more information visit: http://www.gyroscopetx.com and follow us on Twitter (@GyroscopeTx) and on LinkedIn.

References

1 Kavanagh D, Yu Y, Schramm EC, et al. Rare genetic variants in the CFI gene are associated with advanced age-related macular degeneration and commonly result in reduced serum factor I levels. Hum Mol Genet. 2015;24(13):3861-3870.2 Data on File.3 Friedman DS, O'Colmain BJ, Muoz B, et al. Prevalence of age-related macular degeneration in the United States [published correction appears in Arch Ophthalmol. 2011 Sep;129(9):1188]. Arch Ophthalmol. 2004;122(4):564-572.4 Rudnicka AR, Kapetanakis VV et al. Incidence of late-stage age-related macular degeneration in American whites: systematic review and meta-analysis. Am J Ophthalmol 2015;160:85-93.5 Lachmann PJ, Lay E, Seilly DJ, Buchberger A, Schwaeble W, Khadake J. Further studies of the down-regulation by Factor I of the C3b feedback cycle using endotoxin as a soluble activator and red cells as a source of CR1 on sera of different complotype. Clin Exp Immunol. 2016;183(1):150-156.6 Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2014;2:e106116.7 National Eye Institute. Age-Related Macular Degeneration. https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/age-related-macular-degeneration. Accessed July 16, 2020.8 Centers for Disease Control and Prevention. Age-Related Macular Degeneration. https://www.cdc.gov/visionhealth/basics/ced/. Page last reviewed June 3, 2020. Accessed August 4, 2020.

Follow this link:
Gyroscope Therapeutics Announces Initiation of Phase II Programme Evaluating its Investigational Gene Therapy, GT005, for Dry Age-Related Macular...